New Secondary Metabolites with Immunosuppressive Activity from the Phytopathogenic Fungus Bipolaris Maydis.

Xueyan Duan,Xiaosheng Tan,Lianghu Gu,Junjun Liu,Xincai Hao,Li Tao,Hao Feng,Yunfang Cao,Zhengyi Shi,Yulin Duan,Mengyi Deng,Gang Chen,Changxing Qi,Yonghui Zhang
DOI: https://doi.org/10.1016/j.bioorg.2020.103816
IF: 5.307
2020-01-01
Bioorganic Chemistry
Abstract:Three previously undescribed compounds, including a meroterpenoid, guignardone T (1), and two ophiobolintype sesterterpenoids, maydispenoids A and B (2 and 3), along with four known compounds (4-7), were isolated from the phytopathogenic fungus Bipolaris maydis collected from Anoectochilus roxburghii (Wall.) Lindl leaves. The structures of all undescribed compounds were elucidated by spectroscopic analysis, electronic circular dichroism (ECD) calculations and single-crystal X-ray diffraction. Structurally, maydispenoids A was characterized by a fascinating decahydro-3-oxacycloocta[cd]pentalene fragment. It is notable that the compounds 2 and 3 exhibited potential inhibitory activity in anti-CD3/anti-CD28 monoclonal antibodies (mAbs) stimulated murine splenocytes proliferation, with IC50 values of 5.28 and 9.38 mu M, respectively, and also suppress the murine splenocytes proliferation activated by lipopolysaccharide (LPS), with IC50 values of 7.25 and 16.82 mu M, respectively. This is the first report of ophiobolin-type sesterterpenoids as immunosuppressor, and may provide new chemical templates for the development of new immunosuppressive drugs for autoimmune disease treatment.
What problem does this paper attempt to address?